Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]

View source ↗

Summary

This is a Phase 1 study to evaluate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal junction cancer, and sel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Gastroesophageal Junction Cancer
• Myxoid Liposarcoma
• Soft Tissue Sarcoma
• Synovial Sarcoma

Drugs mentioned

• MDG1015 (MDG1015)

Snippet

Sponsor: Medigene AG | Conditions: Epithelial Ovarian Cancer, Gastro-esophageal Junction Cancer | Phase 1 | Status: NOT_YET_RECRUITING